CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 93 filers reported holding CARA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,912 | -88.7% | 30,677 | -60.1% | 0.00% | – |
Q1 2024 | $69,982 | +27.7% | 76,918 | +4.3% | 0.00% | – |
Q4 2023 | $54,790 | -57.0% | 73,763 | -2.8% | 0.00% | – |
Q3 2023 | $127,539 | -41.2% | 75,923 | -0.9% | 0.00% | – |
Q2 2023 | $216,874 | +28436.1% | 76,634 | -50.5% | 0.00% | -100.0% |
Q1 2023 | $760 | -51.7% | 154,817 | +5.8% | 0.00% | -50.0% |
Q4 2022 | $1,572 | -99.9% | 146,385 | +0.7% | 0.00% | 0.0% |
Q3 2022 | $1,360,000 | +9.1% | 145,323 | +6.5% | 0.00% | 0.0% |
Q2 2022 | $1,246,000 | -21.1% | 136,427 | +5.0% | 0.00% | 0.0% |
Q1 2022 | $1,579,000 | -0.2% | 129,977 | +0.1% | 0.00% | 0.0% |
Q4 2021 | $1,582,000 | -21.8% | 129,889 | -0.8% | 0.00% | -33.3% |
Q3 2021 | $2,023,000 | -4.7% | 130,914 | -12.0% | 0.00% | 0.0% |
Q2 2021 | $2,123,000 | +82.5% | 148,808 | +177.8% | 0.00% | +50.0% |
Q1 2021 | $1,163,000 | +34.8% | 53,569 | -6.1% | 0.00% | +100.0% |
Q4 2020 | $863,000 | +23.6% | 57,036 | +3.9% | 0.00% | 0.0% |
Q3 2020 | $698,000 | -35.4% | 54,876 | -13.1% | 0.00% | -50.0% |
Q2 2020 | $1,080,000 | +39.0% | 63,143 | +7.4% | 0.00% | 0.0% |
Q1 2020 | $777,000 | -21.2% | 58,788 | -3.9% | 0.00% | 0.0% |
Q4 2019 | $986,000 | -4.1% | 61,175 | +8.8% | 0.00% | 0.0% |
Q3 2019 | $1,028,000 | -6.3% | 56,239 | +10.3% | 0.00% | 0.0% |
Q2 2019 | $1,097,000 | +20.2% | 51,006 | +9.6% | 0.00% | 0.0% |
Q1 2019 | $913,000 | +59.3% | 46,540 | +5.6% | 0.00% | +100.0% |
Q4 2018 | $573,000 | -14.9% | 44,072 | +56.9% | 0.00% | 0.0% |
Q3 2018 | $673,000 | +31.7% | 28,088 | +5.4% | 0.00% | 0.0% |
Q2 2018 | $511,000 | +63.3% | 26,660 | +5.4% | 0.00% | 0.0% |
Q1 2018 | $313,000 | -2.2% | 25,306 | -3.1% | 0.00% | 0.0% |
Q4 2017 | $320,000 | -24.5% | 26,111 | -15.8% | 0.00% | 0.0% |
Q3 2017 | $424,000 | -9.8% | 31,002 | +1.5% | 0.00% | 0.0% |
Q2 2017 | $470,000 | -2.3% | 30,537 | +16.7% | 0.00% | 0.0% |
Q1 2017 | $481,000 | +103.8% | 26,162 | +3.1% | 0.00% | 0.0% |
Q4 2016 | $236,000 | +15.7% | 25,382 | +4.0% | 0.00% | 0.0% |
Q3 2016 | $204,000 | +28.3% | 24,407 | -26.1% | 0.00% | – |
Q2 2016 | $159,000 | +34.7% | 33,028 | +73.5% | 0.00% | – |
Q1 2016 | $118,000 | -62.5% | 19,041 | +2.0% | 0.00% | -100.0% |
Q4 2015 | $315,000 | +35.8% | 18,666 | +15.1% | 0.00% | 0.0% |
Q3 2015 | $232,000 | +34.9% | 16,216 | +14.4% | 0.00% | 0.0% |
Q2 2015 | $172,000 | – | 14,180 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |